PinnyPeptide

N-Acetyl Epitalon vs NAD+ (Injectable)

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

N-Acetyl Epitalon

Longevity

Acetylated Epitalon variant — more stable, longer-acting form of the telomerase-activating tetrapeptide.

Peptide B

NAD+ (Injectable)

Longevity

Central cellular cofactor — supplemented to support mitochondrial function and sirtuin activity.

Typical vial

5 mg

Typical dose

5,000-10,000 mcg

Half-life

Extended vs. parent Epitalon (acetylation effect)

FDA status

Not FDA approved.

Typical vial

500 mg

Typical dose

50-200 mg (SubQ); 500-1500 mg (IV) mcg

Half-life

~6-10 hours (cellular turnover)

FDA status

Not FDA approved as a therapeutic. Available via compounding…

N-Acetyl Epitalon effects

  • Telomerase activation in dividing cells (extrapolated from Epitalon)
  • Telomere lengthening reported in long-term Russian studies
  • Modulation of pineal melatonin secretion
  • Reported reduction in age-related mortality in elderly study cohorts
  • Potential immune-modulating effects

NAD+ (Injectable) effects

  • Raises cellular NAD+ levels
  • Supports mitochondrial function via electron transport chain
  • Substrate for sirtuin enzymes (deacetylases linked to longevity)
  • Substrate for PARP enzymes (DNA repair)
  • Substrate for CD38 (immune signaling)
  • Subjective reports of energy, mental clarity, mood

N-Acetyl Epitalon side effects

  • Generally well-tolerated in Russian studies (parent Epitalon)
  • Mild injection-site reactions
  • Theoretical: telomerase activation in pre-cancerous cells
  • Limited Western safety data

NAD+ (Injectable) side effects

  • Flushing during IV infusion (most common, mild)
  • Nausea, chest pressure, abdominal discomfort with rapid infusion
  • Headache
  • Subcutaneous: injection-site irritation
  • Possible methylation depletion with chronic high doses

N-Acetyl Epitalon dosing ranges

Longevity research

5-10 mg · Once daily · 10-20 day cycles, repeated 2-3 times per year

NAD+ (Injectable) dosing ranges

IV anti-aging clinic protocol

500-1500 mg · Per infusion, weekly to monthly · Cycle-based

Subcutaneous wellness

50-200 mg · Daily or alternate-day · 2-4 week cycles

Intranasal

20-100 mg · Daily · Cycle-based

N-Acetyl Epitalon vs NAD+ (Injectable) — common questions

What is the difference between N-Acetyl Epitalon and NAD+ (Injectable)?

N-Acetyl Epitalon: Acetylated Epitalon variant — more stable, longer-acting form of the telomerase-activating tetrapeptide. Typical dose 5,000-10,000 mcg. NAD+ (Injectable): Central cellular cofactor — supplemented to support mitochondrial function and sirtuin activity. Typical dose 50-200 mg (SubQ); 500-1500 mg (IV) mcg. Both fall under the Longevity category.

Can you stack N-Acetyl Epitalon and NAD+ (Injectable)?

Stacking N-Acetyl Epitalon with NAD+ (Injectable) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, N-Acetyl Epitalon or NAD+ (Injectable)?

N-Acetyl Epitalon is typically dosed: Once daily for Longevity research. NAD+ (Injectable) is typically dosed: Per infusion, weekly to monthly for IV anti-aging clinic protocol; Daily or alternate-day for Subcutaneous wellness; Daily for Intranasal.

Are N-Acetyl Epitalon and NAD+ (Injectable) FDA approved?

N-Acetyl Epitalon: Not FDA approved. NAD+ (Injectable): Not FDA approved as a therapeutic. Available via compounding pharmacies for off-label use. NAD+ precursors (NR as Niagen, NMN) sold as dietary supplements.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free